FORMATION OF MUTAGENIC DERIVATIVES FROM TRYPTOPHAN PYROLYSIS PRODUCTS (TRP P₁ AND TRP P₂) BY RAT INTESTINAL S9 FRACTION = FORMATION DE DERIVES MUTAGENES A PARTIR DE PRODUITS DE PYROLYSE DU TRYPTOPHANE (TRP P₁ ET TRP P₂) PAR UNE FRACTION S9 INTESTINALE DE RATDE WAZIERS I; DECLOITRE F.1983; MUTATION RESEARCH; ISSN 0027-5107; NLD; DA. 1983; VOL. 119; PP. 103-108; ABS. ENG; BIBL. 12 REF.; GRAPHArticle

Drug-metabolizing enzyme activities in the liver and intestine fo rats exposed to DDT: effects of vitamin A statusDE WAZIERS, I; AZAIS, V.Archives of environmental contamination and toxicology (Print). 1987, Vol 16, Num 3, pp 343-348, issn 0090-4341Article

In vitro study on lipogenesis and exogeneous fatty acid uptake in white adipose tissue of lean and obese Zucker rats aged 10 daysDE WAZIERS, I; PLANCHE, E.Hormone and metabolic research. 1983, Vol 15, Num 11, pp 564-565, issn 0018-5043Article

Human cytochrome P450 2E1 (CYP2E1) : from genotype to phenotypeCARRIERE, V; BERTHOU, F; BAIRD, S et al.Pharmacogenetics (London). 1996, Vol 6, Num 3, pp 203-211, issn 0960-314XArticle

Modification of hepatic drug-metabolizing enzymes in rat fed naturally occurring allyl sulphidesHABER, D; SIESS, M.-H; DE WAZIERS, I et al.Xenobiotica (London. Print). 1994, Vol 24, Num 2, pp 169-182, issn 0049-8254Article

Effects of ethanol and clofibrate on expression of cytochrome P-450 enzymes and epoxide hydrolase in cultures and cocultures of rat hepatocytesPERROT, N; CHESNE, C; DE WAZIERS, I et al.European journal of biochemistry (Print). 1991, Vol 200, Num 1, pp 255-261, issn 0014-2956Article

Drug-metabolizing enzyme expression in human normal, peritumoral and tumoral colorectal tissue samplesDE WAZIERS, I; CUGNENC, P. H; LEROUX, J.-P et al.Carcinogenesis (New York. Print). 1991, Vol 12, Num 5, pp 905-909, issn 0143-3334, 5 p.Article

Cytochrome P450 induction and mutagenicity of 2-aminoanthracene (2AA) in rat liver and gutCARRIERE, V; DE WAZIERS, I; COURTOIS, Y. A et al.Mutation research. 1992, Vol 268, Num 1, pp 11-20, issn 0027-5107Article

Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissuesDE WAZIERS, I; CUGNENC, P. H; YANG, C. S et al.The Journal of pharmacology and experimental therapeutics. 1990, Vol 253, Num 1, pp 387-394, issn 0022-3565, 8 p.Article

Cytochrome P450 mediated bioactivation of methyleugenol to 1'-hydroxymethyleugenol in Fischer 344 rat and human liver microsomesGARDNER, L; WAKAZONO, H; BERGIN, P et al.Carcinogenesis (New York. Print). 1997, Vol 18, Num 9, pp 1775-1783, issn 0143-3334Article

Rat liver epithelial cells express functional cytochrome P450 2E1LERCHE, C; LE JOSSIC, C; FAUTREL, A et al.Carcinogenesis (New York. Print). 1996, Vol 17, Num 5, pp 1101-1106, issn 0143-3334Article

High levels of DNA adducts in human colon are associated with colorectal cancerPFOHL-LESZKOWICZ, A; GROSSE, Y; CARRIERE, V et al.Cancer research (Baltimore). 1995, Vol 55, Num 23, pp 5611-5616, issn 0008-5472Article

Detection and characterization of novel polymorphisms in the CYP2E1 geneFAIRBROTHER, K. S; GROVE, J; DE WAZIERS, I et al.Pharmacogenetics (London). 1998, Vol 8, Num 6, pp 543-552, issn 0960-314XArticle

Relation between inducibility of CYP1A1, GSTM1 and lung cancer in a French populationSTÜCKER, Isabelle; JACQUET, Michele; DE WAZIERS, I et al.Pharmacogenetics (London). 2000, Vol 10, Num 7, pp 617-627, issn 0960-314XArticle

Combined glutathione-S-transferase M1 and T1 genetic polymorphism and tacrine hepatotoxicitySIMON, T; BECQUEMONT, L; MARY-KRAUSE, M et al.Clinical pharmacology and therapeutics. 2000, Vol 67, Num 4, pp 432-437, issn 0009-9236Article

GSTM1, smoking and lung cancer : a case-control studySTÜCKER, I; DE WAZIERS, I; CENEE, S et al.International journal of epidemiology. 1999, Vol 28, Num 5, pp 829-835, issn 0300-5771Article

Microsatellite analysis and response to chemotherapy in head-and-neck squamous-cell carcinomaBLONS, H; CABELGUENNE, A; CARNOT, F et al.International journal of cancer. 1999, Vol 84, Num 4, pp 410-415, issn 0020-7136Article

Metabolism rate of oxodipine in rats and humans : comparison of in vivo and in vitro dataFLINOIS, J.-P; CHABIN, M; EGROS, F et al.The Journal of pharmacology and experimental therapeutics. 1992, Vol 261, Num 1, pp 381-386, issn 0022-3565Article

Comparison of mouse and human colon tumors with regard to phase I and phase II drug-metabolizing enzyme systemsMASSAAD, L; DE WAZIERS, I; RIBRAG, V et al.Cancer research (Baltimore). 1992, Vol 52, Num 23, pp 6567-6575, issn 0008-5472Article

Human CYP2B6: expression, inducibility and catalytic activitiesGERVOT, L; ROCHAT, B; GAUTIER, J. C et al.Pharmacogenetics (London). 1999, Vol 9, Num 3, pp 295-306, issn 0960-314XArticle

Principal xenobiotic-metabolizing enzyme systems in human head and neck squamous cell carcinomaJANOT, F; MASSAAD, L; RIBRAG, V et al.Carcinogenesis (New York. Print). 1993, Vol 14, Num 7, pp 1279-1283, issn 0143-3334Article

p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma : A prospective seriesCABELGUENNE, A; BLONS, H; DE WAZIERS, I et al.Journal of clinical oncology. 2000, Vol 18, Num 7, pp 1465-1473, issn 0732-183XArticle

Human cytochromes P450 expressed in Escherichia coli : production of specific antibodiesBELLOC, C; BAIRD, S; COSME, J et al.Toxicology (Amsterdam). 1996, Vol 106, Num 1-3, pp 207-219, issn 0300-483XArticle

The use of human in vitro metabolic parameters to explore the risk assessment of hazardous compounds: The case of ethylene dibromidePLOEMEN, J.-P. H. T. M; WORMHOUDT, L. W; HAENEN, G. R. M. M et al.Toxicology and applied pharmacology. 1997, Vol 143, Num 1, pp 56-69, issn 0041-008XArticle